echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Cinda BioSurixin® (Adalimumab Injection) prefilled injection form approved for marketing in China

    Cinda BioSurixin® (Adalimumab Injection) prefilled injection form approved for marketing in China

    • Last Update: 2021-09-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On August 23, Cinda Bio announced that the prefilled injection form of Su Lixin® (Adalimumab Injection) was officially approved by the National Medical Products Administration


    The Su Lixin® pre-filled injection form directly fills the injection drug into the syringe, so that the syringe and the drug packaging container are combined into one, which can be used for direct injection


    There are nearly 20 million patients with rheumatoid arthritis, ankylosing spondylitis and psoriasis in China


    Compared with the vial, the active drug component and content of the prefilled injection form remain unchanged, the efficacy and safety are unchanged, and the price remains the same as that of the vial


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.